Showing results (111-120 of 149) with videos related to
Sort By:
Pageof 15
Journal of Hepatology|June 12, 1999
Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infectionY Suzuki, H Kumada, K Ikeda, et al.Journal of Gastroenterology|February 7, 2001
Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis CY Arase, K Ikeda, K Chayama, et al.Journal of Gastroenterology|August 24, 2000
Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial courseY Arase, K Ikeda, K Chayama, et al.Journal of Medical Virology|May 22, 2001
Risk factors of hepatitis C virus-related liver cirrhosis in young adults: positive family history of liver disease and transporter associated with antigen processing 2(TAP2)*0201 AlleleN Akuta, K Chayama, F Suzuki, et al.The American Journal of Gastroenterology|March 10, 2001
Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: a preliminary studyA Tsubota, Y Arase, S Saitoh, et al.Microbiology and Immunology|July 11, 2000
Detection of hantaviral antibodies among patients with hepatitis of unknown etiology in JapanH Kariwa, K Yoshimatsu, K Araki, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 23, 2011
A clinical trial protocol for second line treatment of malignant brain tumors with BNCT at University of TsukubaH Aiyama, K Nakai, T Yamamoto, et al.Digestive Diseases and Sciences|October 1, 1996
Relationship between pretreatment viremia level and response to interferon-alpha therapy in chronic hepatitis C differs in viral type 1 and 2 infectionsA Tsubota, H Kumada, K Chayama, et al.Journal of Gastroenterology|August 19, 1999
Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6M Kobayashi, K Chayama, Y Arase, et al.Journal of Gastroenterology|October 27, 1999
Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapyY Arase, K Ikeda, K Chayama, et al.Pageof 15